Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- Lancet Oncol., Available online 15 October 2014 | doi:10.1016/S1470-2045(14)70473-5
- 2014-10
- 의약학
- 한빛사논문, 상위피인용논문